A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...

Physicians from Bochum have used a cancer treatment method to treat severe autoimmune diseases.

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three ...

Severe autoimmune-mediated neuropathies, such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and ...

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a ...

The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...

Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

Johnson & Johnson (NYSE: JNJ) announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an investigational dual-targeting anti-CD19/CD20 bispecific autologous ...

During a live event, Konstantinos Sdrimas, MD, and community oncologists discussed patient concerns over CAR T-cell therapy ...

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...